다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

PALI

Palisade Bio (PALI)

Palisade Bio Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PALI

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/31	08:44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PALI	Palisade Bio Inc
2024/05/31	08:44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PALI	Palisade Bio Inc
2024/05/30	04:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PALI	Palisade Bio Inc
2024/05/28	19:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PALI	Palisade Bio Inc
2024/05/23	05:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PALI	Palisade Bio Inc
2024/05/23	05:50	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:PALI	Palisade Bio Inc
2024/05/23	05:48	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:PALI	Palisade Bio Inc
2024/05/23	05:45	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:PALI	Palisade Bio Inc
2024/05/21	21:30	GlobeNewswire Inc.	Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Local Bioactivation and Dose Dependent Efficacy Response in Preclinical Mouse Models	NASDAQ:PALI	Palisade Bio Inc
2024/05/20	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PALI	Palisade Bio Inc
2024/05/18	05:51	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:PALI	Palisade Bio Inc
2024/05/17	05:44	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:PALI	Palisade Bio Inc
2024/05/14	21:05	GlobeNewswire Inc.	Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:PALI	Palisade Bio Inc
2024/05/14	05:07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PALI	Palisade Bio Inc
2024/05/11	05:52	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PALI	Palisade Bio Inc
2024/05/11	05:37	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:PALI	Palisade Bio Inc
2024/05/11	05:37	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:PALI	Palisade Bio Inc
2024/05/09	07:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PALI	Palisade Bio Inc
2024/05/09	07:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PALI	Palisade Bio Inc
2024/05/09	06:06	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:PALI	Palisade Bio Inc
2024/05/07	21:30	GlobeNewswire Inc.	Palisade Bio Appoints Margery Fischbein to its Board of Directors	NASDAQ:PALI	Palisade Bio Inc
2024/05/07	20:30	GlobeNewswire Inc.	Palisade Bio Announces Closing of $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules	NASDAQ:PALI	Palisade Bio Inc
2024/05/02	21:30	GlobeNewswire Inc.	Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules	NASDAQ:PALI	Palisade Bio Inc
2024/05/01	21:30	GlobeNewswire Inc.	Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)	NASDAQ:PALI	Palisade Bio Inc
2024/04/23	21:30	GlobeNewswire Inc.	Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach	NASDAQ:PALI	Palisade Bio Inc
2024/04/16	21:30	GlobeNewswire Inc.	Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients’ Stool	NASDAQ:PALI	Palisade Bio Inc
2024/04/11	22:15	GlobeNewswire Inc.	Palisade Bio to Participate in the Virtual Investor Lunch Break Event	NASDAQ:PALI	Palisade Bio Inc
2024/04/10	21:15	GlobeNewswire Inc.	Palisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn’s & Colitis™	NASDAQ:PALI	Palisade Bio Inc
2024/04/04	06:30	GlobeNewswire Inc.	Palisade Bio Announces 1-for-15 Reverse Stock Split	NASDAQ:PALI	Palisade Bio Inc
2024/03/27	21:00	GlobeNewswire Inc.	Palisade Bio Reports Year End 2023 Financial Results and Provides Corporate Update	NASDAQ:PALI	Palisade Bio Inc

검색 관련기사 보기:NASDAQ:PALI

1 2 3 4 5 6 7 8 9 10 다음 >>

BNP PARIBAS ISSUANCE

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관